US FDA/CFSAN - BSE and Cosmetics: FDA Risk Assessment and Management Perspectives - Slide 25 - BSE/ v-CJD: OCAC Role In Process of BSE Risk Analysis- I

US FDA/CFSAN - BSE and Cosmetics: FDA Risk Assessment and Management Perspectives December 7, 2006

US FDA/CFSAN

BSE and Cosmetics: FDA Risk Assessment and Management Perspectives

December 7, 2006

BSE/ v-CJD: OCAC Role In Process of BSE Risk Analysis- I

1992 - Education and Outreach
- Intra-Agency OCAC-sponsored Seminar by CVM
Guidance to Industry
- 1994, 1996 - "Letters to Manufacturers of FDA-Regulated Products (Dietary Supplements and Cosmetics)"
FDA TSE Advisory Committee (TSEAC)
- OCAC Participation in FDA Inter-Center TSE Working Group on Tallow (mid 1990s)
- OCAC Presentation on Tallow to FDA-TSEAC (April 1998)